RxDoctor Payments Data

Sarah Lewis

Family · Marshfield, MONPI 1346657145

Payments from drug & device makers

$4,432in general payments, 2019–2025

Across 246 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Lilly USA, LLC$503
  • Novo Nordisk$449
  • AbbVie$305
  • Pfizer$229
  • Astellas Pharma US Inc$205
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$4,32398%
  • Education$1092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,432 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol45$52,463
OzempicSemaglutide34$51,562
EliquisApixaban45$29,634
Spiriva RespimatTiotropium Bromide16$9,424
XareltoRivaroxaban13$7,935
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,959
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,048
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,473
Duloxetine Hcl39$1,303
Levothyroxine Sodium112$1,061
Rosuvastatin Calcium53$1,019
Tizanidine Hcl85$837
Gabapentin63$754
Atorvastatin Calcium108$729
Amitriptyline Hcl48$721

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$1,155$52,46345 claims
Novo NordiskOzempic$449$51,56234 claims
PfizerEliquis$229$29,63445 claims
Boehringer IngelheimSpiriva Respimat$81$9,42416 claims
Johnson & JohnsonXarelto$12$7,93513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Marshfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →